Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Omega-3 review

This article was originally published in The Tan Sheet

Executive Summary

There is "no strong evidence of reduced risk of total mortality or combined cardiovascular events in participants taking additional omega-3 fats," a systematic review of 89 studies published online by the British Medical Journal concludes. Lee Hooper, School of Medicine, University of East Anglia, Norwich, et al., analyzed 48 randomized controlled trials and 41 cohort studies and conclude there are "substantial variations" among the findings. "Neither RCTs nor cohort studies showed significantly increased risks of cancer or stroke with higher intake of omega-3, but there were too few events to rule out important events," the authors state. Current UK recommendations encouraging the general public to eat more oily fish "should continue at present, but the evidence should be reviewed regularly," Hooper et al. add. According to an accompanying editorial, "the review shows that the evidence for a reduction in cardiovascular events and mortality is less conclusive than we believed"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099222

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel